Position in ZNTL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,305,615
+$1,414,392 QoQ
Shares Held
1,412,656
+0.8% QoQ
Ownership
1.98%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZNTL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Opaleye Management Inc. holds $427,835,777 across 44 Biotechnology names. ZNTL ranks #33 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SLGL |
Sol-Gel Technologies Ltd.
|
500,000 | $39,610,000 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
390,000 | $32,826,300 | |
| 3 | IRON |
Disc Medicine, Inc.
|
421,000 | $26,918,740 | |
| 4 | URGN |
UroGen Pharma Ltd.
|
1,430,000 | $25,711,400 | |
| 5 | CBIO |
Crescent Biopharma, Inc.
|
1,312,615 | $24,112,737 | |
| 6 | STOK |
Stoke Therapeutics, Inc.
|
700,000 | $22,792,000 | |
| 7 | RZLT |
Rezolute, Inc.
|
6,300,000 | $19,215,000 | |
| 8 | MGTX |
MeiraGTx Holdings plc
|
2,123,259 | $18,387,422 |
All Filings in ZNTL
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,305,615 | 1,412,656 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,891,223 | 1,400,906 | Shares | Sole | 2026-04-13 | |
| 2025-09-30 | $477,990 | 316,550 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,232,188 | 1,924,300 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $3,156,150 | 1,985,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,355,525 | 1,767,500 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,558,560 | 967,000 | Shares | Sole | 2024-11-14 | |
| 2024-03-31 | $3,152,000 | 200,000 | Shares | Sole | 2024-05-29 | |
| 2022-12-31 | $3,373,450 | 167,500 | Shares | Sole | 2023-02-10 | |
| No filing history on record for this holder in this stock. | ||||||